Thermo Fisher Scientific, PerkinElmer, Affymetrix, Illumina, Bruker BioSciences, Beckman Coulter, Sigma-Aldrich, Sequenom, Agilent Technologies, Roche, Ventana, Celera | GenomeWeb
Thermo Fisher’s Q3 Revenues Rise 7 Percent
 
Thermo Fisher Scientific last week said that its third-quarter revenues rose 7 percent to $2.4 billion on a pro forma basis.
 
The company also hinted in a statement that the “highly fragmented” market in which it plays “presents opportunities” to make additional acquisitions.
 
Thermo Fisher stressed that last year's results reflect Thermo Electron's operations before its merger with Fisher Scientific last November.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.